CHICAGO (GenomeWeb) – Genome informatics vendor DNAnexus said today that it will support the AstraZeneca Centre for Genomics Research in its efforts to analyze as many as 2 million genomes over the next 10 years in the name of more precise drug discovery.

Financial terms were not disclosed.

Under the agreement, Mountain View, California-based DNAnexus indicated that it would work with AstraZeneca to develop a "secure genomics informatics environment" to manage the wide-scale sequencing analytics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.